Arkolith/Insider Trading/TERN/Form 4

Kuriakose Emil

Chief Medical OfficerTerns Pharmaceuticals, Inc. (TERN) · full profile →Form 4 · filed Jan 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$45K
Net Open-Market Flow
-$45K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 2, 2026Sell(S)955$38.36$37K50K
Jan 2, 2026Sell(S)200$39.60$8K51K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001892413-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML